Novo's shares have risen more than three-fold since June 2021 when it launched Wegovy in the US, last year becoming Europe's most valuable listed company, ahead of LVMH.
Ozempic maker Novo Nordisk surges past Tesla with market value of $566B
New York Post - 7 Mar 2024 18:52
Novo's shares have risen more than three-fold since June 2021 when it launched Wegovy in the US, last year becoming Europe's most valuable listed company, ahead of LVMH.
Share this Article
Recommended